Partager Partager sur facebook Partager sur twitter Partager sur google+
-A +A

imprimer la page

Références

La liste des publications mentionnées dans ce dossier.

(1) SF3B1 mutations are associated with alternative splicing in uveal melanoma

Simon J. Furney, Malin Pedersen, David Gentien, Amaury G. Dumont, Audrey Rapinat, Laurence Desjardins, Samra Turajlic, Sophie Piperno-Neumann, Pierre de la Grange, Sergio Roman-Roman, Marc-Henri Stern, Richard Marais

Cancer Discovery, 16 juillet 2013, DOI: 10.1158/2159-8290

 

(2) Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma.

Cassoux N, Rodrigues MJ, Plancher C, Asselain B, Levy-Gabriel C, Lumbroso-Le Rouic L, Piperno-Neumann S, Dendale R, Sastre X, Desjardins L, Couturier J.

Br J Ophthalmol. 2014 Jun;98(6):769-74. doi: 10.1136/bjophthalmol-2013-303867

 

(3) Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients.

Piperno-Neumann S, Servois V, Mariani P, Plancher C, Lévy-Gabriel C, Lumbroso-Le Rouic L, Couturier J, Asselain B, Desjardins L, Cassoux N

J Fr Ophtalmol. 2015 May 12. pii: S0181-5512(15)00159-X. doi: 10.1016/j.jfo.2015.04.005.

 

(4) Diffusion-weighted MRI for uveal melanoma liver metastasis detection

Mathilde Wagner, Pascale Mariani, François Clément Bidard, Manuel Jorge Rodrigues, Fereshteh Farkhondeh, Nathalie Cassoux, Sophie Piperno-Neumann, Slavomir Petras, Vincent Servois

Eur Radiol, DOI 10.1007/s00330-015-3662-y

 

(5) Multi-modal acousto-optic/ultrasound imaging of ex vivo liver tumors at 790 nm using a Sn2 P2 S6 wavefront adaptive holographic setup.

Laudereau JB, A La Guillaume EB, Servois V, Mariani P, Grabar AA, Tanter M, Gennisson JL, Ramaz F.

J Biophotonics. 2014 Sep 18;9999(9999). doi: 10.1002/jbio.201400071. [Epub ahead of print]

 

(6) Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

Madic J, Piperno-Neumann S, Servois V, Rampanou A, Milder M, Trouiller B, Gentien D, Saada S, Assayag F, Thuleau A, Nemati F, Decaudin D, Bidard FC, Desjardins L, Mariani P, Lantz O, Stern MH.

Clin Cancer Res. 2012 Jul 15;18(14):3934-41. doi: 10.1158/1078-0432.CCR-12-0309.

 

(5) High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.

Laurent C, Valet F, Planque N, Silveri L, Maacha S, Anezo O, Hupe P, Plancher C, Reyes C, Albaud B, Rapinat A, Gentien D, Couturier J, Sastre-Garau X, Desjardins L, Thiery JP, Roman-Roman S, Asselain B, Barillot E, Piperno-Neumann S, Saule S.

Cancer Res. 2011 Feb 1;71(3):666-74. doi: 10.1158/0008-5472.CAN-10-0605

 

(7) Establishment of novel cell lines recipulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target

Nabil Amirouchene-Angelozzi, Fariba Nemati, David Gentien, André Nicolas, Amaury Dumont, Guillaume Carita, Jacques Camonis, Laurence Desjardins, Nathalie Cassoux, Sophie Piperno-Neumann, Pascale Mariani, Xavier Sastre, Didier Decaudin, Sergio Roman-Roman

Molecular Oncology, juin 2014, DOI: 10.1016/j.molonc.2014.06.004

Céline Giustranti
08/06/2015